切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2009, Vol. 03 ›› Issue (01) : 77 -81. doi: 10.3877/cma.j.issn.1674-0807.2009.01.013

综述

ERα 磷酸化与乳腺癌内分泌疗效关系的研究进展
徐东宏1, 范忠林2, 耿翠芝2, 胡崇珠1   
  1. 1.071000 河北保定,保定市第一中心医院乳腺外科
    2.050011 河北石家庄,河北医科大学第四附属医院外一科
  • 收稿日期:2008-08-07 出版日期:2009-02-01

Advances in the study of the relationship between ERα phosphorylation and endocrine therapeutic effect in breast cancer

Dong-hong XU, Zhong-lin FAN, Cui-zhi GENG, Chongzhu Hu   

  • Received:2008-08-07 Published:2009-02-01
引用本文:

徐东宏, 范忠林, 耿翠芝, 胡崇珠. ERα 磷酸化与乳腺癌内分泌疗效关系的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2009, 03(01): 77-81.

Dong-hong XU, Zhong-lin FAN, Cui-zhi GENG, Chongzhu Hu. Advances in the study of the relationship between ERα phosphorylation and endocrine therapeutic effect in breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2009, 03(01): 77-81.

[1]
沈镇宙,邵志敏. 现代乳腺肿瘤学进展. 上海:上海科学技术文献出版社,2002:187.
[2]
Deborah D A. Estrogen receptor phosphorylation. Steroids,2003,68:1 -9.
[3]
Joel P B,Traish A,Lannigan D. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem,1998,273:13 317 -13 323.
[4]
Chen D, Washbrook E, Sarwar N, et al. Phosphorylation of humen estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene,2002,21:4921 -4931.
[5]
Murphy L C, Cherlet T, Adeyinka A, et al. Phosphoserine-118 estrogen receptor-α detection in human breast tumors in vivo. Clin Cancer Res,2004,10:1354 -1359.
[6]
Yamashita H, Nishio M, Kobayashi S, et al. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer. Breast Cancer Research,2005,7:753 -764.
[7]
Murphy L C, Niu Y L, Snell L, et al. Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen. Clin Cancer Res,2004,10:5902 -5906.
[8]
Castano E, Chen C W, Vorojeikina D P, et al. The role of phosphorylation in human estrogen receptor function. J Steroid Biochem Mol Biol,1998,65:101 -110.
[9]
王甜甜,马荣.乳腺癌内分泌治疗研究现状.中国现代普通外科进展,2004,7:260 -262.
[10]
Sarwar N, Kim J S, Jiang J, et al. Phosphorylation of ER alpha at serine 118 in primary breast cancer and in tamoxifenresistant tumours is indicative of a complex role for ER alpha phosphorylation in breast cancer progression. Endocr Relat Cancer,2006,13:851 -861.
[11]
Santen R J, Song R X, McPherson R, et al. The role of mitogen-activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol,2002,80:239 -256.
[12]
Jiang J, Sarwar N, Peston D, et al. Phosphorylation of estrogen receptor-alpha at Ser167 is indicative of longer diseasefree and overall survival in breast cancer patients. Clin Cancer Res,2007,13:5769 -5776.
[13]
Yamashita H, Nishio M, Toyama T, et al. Low phosphorylation of ER serine 118 and high phosphorylation of ERα serine 167 improve survival in ER-positive breast cancer ,Endocr Relat Cancer,2008,15:755 -763.
[14]
Sarwar N, Kim J S, Jiang J, et al. Phosphorylation of estrogen receptor α at serine 118 in human breast tumours, ASCO Meeting Abstracts,2005,23:9576.
[15]
Zoubir M, Mathieu M C, Mazouni C, et al. Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy. Ann Oncol,2008,19:1402 -1406.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要